OutPerformDaily

  • Tech Stocks
  • Cannabis Stocks
  • Index Funds
  • International
  • Short
  • Stock Picks

Lost Password?
Lilly’s oral GLP-1, orforglipron, is successful in third Phase 3 trial, triggering global regulatory submissions this year for the treatment of obesity

Lilly’s oral GLP-1, orforglipron, is successful in third Phase 3 trial, triggering global regulatory submissions this year for the treatment of obesity

Form 8.3 – Aqua Acquisition Sub LLC (subsidiary of Qualcomm Incorporated)

Form 8.3 – Aqua Acquisition Sub LLC (subsidiary of Qualcomm Incorporated)

Earnings To Watch: Nvidia (NVDA) Reports Q2 Results Tomorrow

Earnings To Watch: Nvidia (NVDA) Reports Q2 Results Tomorrow

Fox channels may go dark on YouTube TV from Wednesday over payment dispute

Fox channels may go dark on YouTube TV from Wednesday over payment dispute

Inside Elon Musk’s suit against Apple and OpenAI: ‘This is a tale of two monopolists’

Inside Elon Musk’s suit against Apple and OpenAI: ‘This is a tale of two monopolists’

What’s Going On With AMD Stock Monday?

What’s Going On With AMD Stock Monday?

OutPerformDaily
  • Tech Stocks
  • Cannabis Stocks
  • Index Funds
  • International
  • Short
  • Stock Picks
OutPerformDaily
  • Tech Stocks
  • Cannabis Stocks
  • Index Funds
  • International
  • Short
  • Stock Picks
3rdPartyFeeds • News

FA Center: Why shares of Chinese companies could soon be more expensive

December 8, 2020

Congress approves delisting Chinese companies that flout U.S. accounting rules — and investors pay the price.

Read More...

3rdPartyFeeds

Is FB Stock A Buy? Facebook Rebounds Bullishly Despite Imminent Antitrust Move

December 8, 2020

FB stock a buy? The FANG stock is showing bullish action despite state and federal antitrust lawsuits against Facebook that could come any day. Read More...

3rdPartyFeeds

This E-Commerce Stock is Up 150% So Far in 2020. Here’s Why It’s Still a Buy.

December 8, 2020

Investors will often avoid a stock that's had a stellar run. They could be missing out on future gains. Read More...

3rdPartyFeeds

Why Amazon ‘was invented for the pandemic,’ and how AWS could be the most valuable company in the world

December 8, 2020

New York University Stern School of Business professor Scott Galloway previously believed Amazon.com Inc. would outlive the other biggest companies in tech...

3rdPartyFeeds • News

NewsWatch: The stock market is ‘very, very vulnerable’ at these euphoric levels and a ‘timeout’ is in order, investor warns

December 8, 2020

Peter Boockvar, chief investment officer at Bleakley Advisory Group, warned that stocks are teetering at dangerous levels amid the kind of euphoria last seen...

3rdPartyFeeds • News

Coronavirus Update: U.S. suffers deadliest week from coronavirus since pandemic broke out

December 8, 2020

The U.S. has set another grim milestone in the coronavirus pandemic, averaging the most deaths from COVID-19 in a week since the start of the outbreak, as...

3rdPartyFeeds

Cisco Updates Webex Video Conferencing in Bid to Fend Off Zoom

December 8, 2020

(Bloomberg) -- Cisco Systems Inc., the biggest maker of networking equipment, is upgrading its Webex conferencing service to beat back challenges from Zoom...

3rdPartyFeeds

Cisco Wakes Up and Overhauls Webex. Look Out, Zoom Video.

December 8, 2020

Cisco is kicking off a determined effort to take back the videoconferencing market with a slew of new updates to its Webex software—as well some new hardware...

3rdPartyFeeds

Bill Gates’ favorite reads of 2020: Wide-ranging books on science, history and social justice

December 8, 2020

Bill Gates is out with his annual list of best reads, and as usual they are an eclectic bunch. Roger Federer is one example, as he played all kinds of sports...

3rdPartyFeeds

Vatican, Business Leaders Work To Improve Capitalism

December 8, 2020

The Vatican has partnered with several investment and business leaders to work on reforming capitalism “into a powerful force for the good of humanity.” Read...

Previous 1 … 5,101 5,102 5,103 5,104 5,105 … 8,351 Next
Indices by TradingView
Lilly’s oral GLP-1, orforglipron, is successful in third Phase 3 trial, triggering global regulatory submissions this year for the treatment of obesity

Lilly’s oral GLP-1, orforglipron, is successful in third Phase 3 trial, triggering global regulatory submissions this year for the treatment of obesity

August 26, 2025
Form 8.3 – Aqua Acquisition Sub LLC (subsidiary of Qualcomm Incorporated)

Form 8.3 – Aqua Acquisition Sub LLC (subsidiary of Qualcomm Incorporated)

August 26, 2025
Earnings To Watch: Nvidia (NVDA) Reports Q2 Results Tomorrow

Earnings To Watch: Nvidia (NVDA) Reports Q2 Results Tomorrow

August 25, 2025
Fox channels may go dark on YouTube TV from Wednesday over payment dispute

Fox channels may go dark on YouTube TV from Wednesday over payment dispute

August 25, 2025
Inside Elon Musk’s suit against Apple and OpenAI: ‘This is a tale of two monopolists’

Inside Elon Musk’s suit against Apple and OpenAI: ‘This is a tale of two monopolists’

August 25, 2025

Categories

  • 3rdPartyFeeds
  • Cannabis Stocks
  • Index Funds
  • International
  • News
  • Short
  • Stock Picks
  • Tech Stocks
  • Uncategorized
Indices by TradingView
While subscribers receive the benefit of Outperformdaily opinions, none of the information contained therein constitutes a recommendation from Outperformdaily that any particular security, portfolio of securities, transaction, option, or investment strategy is suitable for any specific person. You further understand that we will not advise you personally concerning the nature, potential, value or suitability of any particular security, portfolio of securities, transaction, investment strategy or other matter. To the extent any of the information contained in Outperformdaily may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person. Outperformdaily’s past results are not necessarily indicative of future performance. All investments are subject to loss. Our employees and writters typically personally invest in all recommendations, but they are not obligated too. Our employees and writters are prohibited from taking an opposite position from which they write about.